Abstract
The discovery of the anxiolytic properties of antidepressants (ADs) represented a great advance in the treatment of anxiety disorders. Clinical observations that selective serotonin re-uptake inhibitors are the first choice treatment for these pathologies highlighted the importance of serotonin in this process. Other evidence shows that the therapeutic effects of ADs develop only after ch…